Cargando…

Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review

INTRODUCTION: Metabolomics is an emerging area of research and has the potential to identify clinical biomarkers for predicting or diagnosing cystic fibrosis (CF) pulmonary exacerbations (PEx). OBJECTIVE: To identify clinically promising metabolites across different sample sources that can be used t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Anna-Lisa V., Haas, Dominic, Bouchard, Mégane, Quon, Bradley S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192952/ https://www.ncbi.nlm.nih.gov/pubmed/35712620 http://dx.doi.org/10.3389/fped.2022.896439

Ejemplares similares

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Quon, Bradley S., et al.
Publicado: (2014)

Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics
por: Dong, Kang, et al.
Publicado: (2019)

Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imaging
por: Landini, Nicholas, et al.
Publicado: (2023)

Body Composition and Pulmonary Function in Cystic Fibrosis
por: Sheikh, Saba, et al.
Publicado: (2014)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
por: Quinn, Robert A., et al.
Publicado: (2016)

Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations
por: Sharma, Ashutosh, et al.
Publicado: (2017)

Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data
por: Garazzino, Silvia, et al.
Publicado: (2020)

Vasculitis in Cystic Fibrosis
por: Sposito, Francesca, et al.
Publicado: (2020)

Editorial: Cystic Fibrosis in Children
por: Karadag, Bülent Taner, et al.
Publicado: (2022)

Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening
por: Esteves, Cibele Zanardi, et al.
Publicado: (2018)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016)

IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations
por: Solomon, George M., et al.
Publicado: (2013)

Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
por: Li, Qiyu, et al.
Publicado: (2022)

Patient knowledge and pulmonary medication adherence in adult patients with cystic fibrosis
por: Lin, Ann Hsu-An, et al.
Publicado: (2017)

Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review
por: Terlizzi, Vito, et al.
Publicado: (2022)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
por: Dagenais, Renée VE., et al.
Publicado: (2022)

Patient and Provider Experience With Cystic Fibrosis Telemedicine Clinic
por: Hendra, Kalen, et al.
Publicado: (2021)

Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable
por: Coverstone, Andrea M., et al.
Publicado: (2021)

Translational Research in Cystic Fibrosis: From Bench to Beside
por: Garcia, Laura de Castro e, et al.
Publicado: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
por: Dagenais, Renée V. E., et al.
Publicado: (2020)

Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis
por: Nathan, Anna Marie, et al.
Publicado: (2017)

Skeletal muscle contributions to reduced fitness in cystic fibrosis youth
por: Tomlinson, Owen William, et al.
Publicado: (2023)

Editorial: New insights into caring for pediatric patients with cystic fibrosis
por: Bui, Stephanie, et al.
Publicado: (2023)

Adherence, reliability, and variability of home spirometry telemonitoring in cystic fibrosis
por: Beaufils, Fabien, et al.
Publicado: (2023)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
por: Wells, J. Michael, et al.
Publicado: (2016)

Variability of FEV(1) and Criterion for Acute Pulmonary Exacerbation
por: Jenkins, Bradlee A., et al.
Publicado: (2014)

Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients
por: Wojewodka, Gabriella, et al.
Publicado: (2014)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4nj6fj5v889r0o96ru8t1dd7rh